Every now and then I collect a bunch of recent science good news that I’ve come across. Here are some past ‘good news’ posts. Today’s post includes such a recent collection and some funny stuff too at the end. Enjoy! BTW, science is not necessarily all about stem cells, right? Talk about good news. 1,000th […]
Good news science digest: HIV, brain, CRISPR, cats vs. dogs, space, & more Read More »
The exciting and sometimes downright crazy giant stem cell ecosystem of legit research and unproven stem cell clinics could use a dose of good news now and then. In today post, I highlight some upbeat news and some interesting recent pubs. Enjoy! From a team led by Hina Chaudhry, MD, Director of Cardiovascular Regenerative Medicine at
Stem cell good news & pubs in late May 2019 Read More »
There’s nothing like stem cell good news and interesting publications to perk one up on a Monday. Enjoy. What recent papers have struck you as exciting? Novel stem cell-based cancer approaches (Part 1) It was exciting when Fate Therapeutics got the first induced pluripotent stem cell (IPSC) IND in the U.S. for their IPSC-derived natural killer cell
Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs Read More »
In the past month or two there has been a steady stream of good news in the stem cell and regenerative medicine world. Here are three examples starting with Fate Therapeutics. Fate Therapeutics Fate Therapeutics announced the first US IND for an induced pluripotent stem cell (IPSC)-related product. Its cleared product, FT500, is an off-the-shelf
Stem cell & regenerative medicine good news including Fate Therapeutics Read More »
Magenta Therapeutics is a biotech company with a portfolio including stem cell products. Their most well known investigational drug product is an expanded umbilical cord stem cell product called MGTA-456, an “ex-Novartis” product. Magenta just released new trial data on MGTA-456, which I see as a case of good news-bad news, and investors seem to
Magenta Therapeutics Good News-Bad News Trial Data Read More »
Sometimes we could all use a jolt of good news and cool science. Those of us in the stem cell field probably get tired at times of all the bad-ish, even if important news (like this from Michael Hiltzik of the LA Times) out there surrounding certain unproven stem cell offerings and also clinics that
Some stem cell good news, stuff for debate, & cool pubs Read More »
Periodically I also try to post (as I am today) specifically about stem cell good news amongst all the swirling developments out there. You can see the most recent past installment focused on good news here that include vascularized organoids. I recently stumbled on this quote that for me linked up the potential of stem cells
3 bits of stem cell good news Read More »
There’s some recent stem cell good news out there including new papers and biotech developments. The stem cell and regenerative medicine field is really diverse and runs the gamut from really worrying stuff to very exciting, legit developments. In this post, I’m going to focus on the encouraging recent developments. What do I see as
Stem cell good news on biotechs & cool new organoid paper Read More »
I’ve got some TGIF recommend reads on stem cells, etc, but first, what a week, right? We need more action on preventing gun violence. It’s a uniquely American health crisis that doesn’t have to be. There’s no real, common sense reason that gun control can’t reduce mass killings of our kids and others like the
TGIF: Guns, stem cells, science weekends reads & good news Read More »
I can see many reasons to be jolly on the regenerative medicine front as we get deeper into the holiday season as there is quite a lot of stem cell good news even if there is also some not so good news. In today’s post the focus is on the good news of late. Semma
Stem cell good news for the holidays: biotechs, FDA, organoids Read More »